Active Ingredient(s):Bepotastine Besilate FDA Approved: * September 8, 2009 Pharm Company: *ISTA PHARMS Category:Allergies, Cough & Cold
Bepotastine (Talion, Bepreve) is a 2nd generation antihistamine. It was approved in Japan for use in the treatment of allergic rhinitis and urticaria/pruritus in July 2000 and January 2002, respectively. It is currently marketed in the United States as an eye drop under the brand-name Bepreve, by ISTA Pharmaceuticals, a subsidiary of Bausch + Lomb.
2 Marketing history
3 Sales and patents
4 Clinical trials
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion